New clinic provides early-phase clinical trials for patients with solid tumors.
New Chemotherapy Regimen Proves Effective in Treating Amyloidosis
The addition of daratumumab to existing regimens is a game changer for patients with relapsed/refractory primary amyloidosis.
Treatment Guidelines Established for Idiopathic Multicentric Castleman Disease
The establishment of stratification, treatment guidelines and therapeutic response criteria should provide physicians with guidance in choosing appropriate therapies and assessing responses in this rare disease.